Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
November 16, 2026 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 5, 2026 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 5, 2026 10-Q Quarterly report which provides a continuing view of a company's financial position EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 23, 2026 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 14, 2026 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2026 4 Statement of changes in beneficial ownership of securities View HTML
August 5, 2026 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 5, 2026 10-Q Quarterly report which provides a continuing view of a company's financial position EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 5, 2026 S-8 Securities offered to employees pursuant to employee benefit plans XML - XBRL INSTANCE DOCUMENT View HTML
July 1, 2026 4 Statement of changes in beneficial ownership of securities View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics
180 Third Ave, Floor 2
Waltham, MA 02452

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us